It is well known that tobacco is the leading cause of preventable death in the world (WHO, 2011). However, the associations between smoking and mental health are less well established. Smokers often want to quit, but the belief that cigarettes can be used to regulate mood can often deter them, and this is especially true [read the full story…]
Tobacco use is the single most important preventable cause of mortality and morbidity in developed countries. However, what is less widely appreciated is that as the overall prevalence of smoking has declined, tobacco use has become an increasingly important driver of health inequalities. For example, the prevalence of smoking in the United Kingdom has declined [read the full story…]
It’s well known that individuals with mental illness smoke nearly twice as much as those without a psychiatric disorder (Gfroerer et al, 2013; Lasser et al, 2000), and are more addicted to nicotine, smoke more cigarettes per day, and find it more difficult to quit (Lasser et al, 2000). However, studies have shown that individuals [read the full story…]
While the organisation’s name may change frequently, currently National Institute for Health and Care Excellence (NICE), its role remains constant – to provide clear published guidance on the role of treatment options within the NHS. The publication of new NICE guidance represents a significant event as clinical recommendations shape the nature of provided care nationally [read the full story…]
Smoking is a major cause of morbidity and mortality across the world and accounts for over 60% of deaths in people who do smoke. The World Health Organisation estimates that tobacco kills almost 6 million people per year, with 5 million as a result of direct tobacco use. Innovative treatment approaches aimed at improving smoking [read the full story…]
Smoking is a major preventable cause of morbidity and premature mortality throughout the world. There are an estimated 460,000 hospital admissions attributable to smoking in people aged over 35 every year, with an average annual cost to the NHS of £2.7 billion. Many strategies exist to help people give up smoking. The most common are [read the full story…]
Varenicline is a prescription drug to help people stop smoking that works by stimulating the nicotine receptors in the brain to reduce cravings and decrease the pleasure that results from smoking. Quit attempts aided by varenicline are up to 2-3 times more successful than those without (Cahill et al 2009 and 2012). However, following the [read the full story…]
There is a high rate of co-morbidity between depression and smoking; rates of smoking are approximately double in those with depression compared with the general population. In addition, smokers with depression tend to have higher rates of nicotine dependence, suffer greater negative affect during abstinence/withdrawal, are more likely to fail in quit attempts, and are [read the full story…]
Over 40% of all cigarettes smoked in England are smoked by people with severe mental illnesses. This group are more likely to become physically ill than the rest of the population, but they are less likely to be given help to quit. Smoking is especially common among people with mental health problems: whilst 1 in [read the full story…]
During 2010/11 there were 1.53 million hospital admissions for illnesses directly attributable to smoking in the UK. These admissions, along with other smoking-related expenses, cost the NHS approximately £5 billion pounds per year. Fortunately, the NHS is spending £88.2 million per year on cessation treatments, many of which have been repeatedly demonstrated to be highly [read the full story…]
